A team of US-based researchers has concluded that high-dose vitamin D3 does not provide any additional benefit for patients suffering from metastatic colorectal cancer. This conclusion was reached following a randomized phase 3 clinical trial led by researchers from the Dana-Farber Cancer Institute in the US.